KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dorman Products (DORM) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Dorman Products (DORM) over the last 16 years, with Q3 2025 value amounting to -$280000.0.

  • Dorman Products' Asset Writedowns and Impairment fell 41460.67% to -$280000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $390000.0, marking a year-over-year decrease of 7994.86%. This contributed to the annual value of $90000.0 for FY2024, which is 9804.01% down from last year.
  • Latest data reveals that Dorman Products reported Asset Writedowns and Impairment of -$280000.0 as of Q3 2025, which was down 41460.67% from $340000.0 recorded in Q2 2025.
  • Dorman Products' Asset Writedowns and Impairment's 5-year high stood at $2.7 million during Q2 2023, with a 5-year trough of -$387000.0 in Q3 2023.
  • Moreover, its 5-year median value for Asset Writedowns and Impairment was $27000.0 (2022), whereas its average is $280157.9.
  • Data for Dorman Products' Asset Writedowns and Impairment shows a peak YoY increase of 3108333.33% (in 2023) and a maximum YoY decrease of 153333.33% (in 2023) over the last 5 years.
  • Over the past 5 years, Dorman Products' Asset Writedowns and Impairment (Quarter) stood at $120000.0 in 2021, then crashed by 95.0% to $6000.0 in 2022, then skyrocketed by 31083.33% to $1.9 million in 2023, then plummeted by 99.14% to $16000.0 in 2024, then tumbled by 1850.0% to -$280000.0 in 2025.
  • Its Asset Writedowns and Impairment stands at -$280000.0 for Q3 2025, versus $340000.0 for Q2 2025 and $314000.0 for Q1 2025.